Primary Site >> Pancreatic Cancer

Gene >> MMRN1

Journal: Integr Comp Biol. 2006 Dec 1;46(6):1072-1081.
Title: Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health.
Author: Walsh, Catherine J|Luer, Carl A|Bodine, A B|Smith, Clayton A|Cox, Heather L|Noyes, David R|Maura, Gasparetto
PMID: 19343108
Journal: BMC Cancer. 2010 Mar 9;10:86.
Title: Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study.
Author: Pelzer, Uwe|Arnold, Dirk|Govercin, Mehmet|Stieler, Jens|Doerken, Bernd|Riess, Hanno|Oettle, Helmut
PMID: 20214798
Journal: Cancer Cell. 2016 Jun 13;29(6):780-782.
Title: Tension and Transformation in Pancreas Cancer: Can Phenotype Break Free from the Chrysalis of Genotype?
Author: DuFort, Christopher C|Hingorani, Sunil R
PMID: 27300433
Journal: J Control Release. 2018 Oct 2;290:1-10.
Title: Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
Author: Mardhian, Deby F|Storm, Gert|Bansal, Ruchi|Prakash, Jai
PMID: 30287265